Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Pollen Allergenic Extract [EPC]
Juniperus Virginiana Pollen is a non-standardized allergenic extract used primarily in the diagnosis and treatment of IgE-mediated allergic diseases. It belongs to the class of Non-Standardized Pollen Allergenic Extracts [EPC].
Name
Juniperus Virginiana Pollen
Raw Name
JUNIPERUS VIRGINIANA POLLEN
Category
Non-Standardized Pollen Allergenic Extract [EPC]
Drug Count
31
Variant Count
33
Last Verified
February 17, 2026
About Juniperus Virginiana Pollen
Juniperus Virginiana Pollen is a non-standardized allergenic extract used primarily in the diagnosis and treatment of IgE-mediated allergic diseases. It belongs to the class of Non-Standardized Pollen Allergenic Extracts [EPC].
Detailed information about Juniperus Virginiana Pollen
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Juniperus Virginiana Pollen.
Juniperus Virginiana Pollen, commonly derived from the Eastern Red Cedar (a species of juniper native to eastern North America), is a biological substance utilized in the field of clinical allergy and immunology. It is classified pharmacologically as a Non-Standardized Pollen Allergenic Extract [EPC]. Unlike standardized extracts, which have a defined potency measured in Bioequivalent Allergy Units (BAU), non-standardized extracts like Juniperus Virginiana are typically prepared based on weight-to-volume (w/v) ratios or Protein Nitrogen Units (PNU).
This extract is primarily used for the diagnosis of hypersensitivity (allergic) reactions via skin testing and for allergen immunotherapy (AIT), often referred to as 'allergy shots.' The goal of using this extract is to identify and subsequently desensitize patients who suffer from seasonal allergic rhinitis (hay fever), allergic conjunctivitis, or pollen-induced asthma triggered by the Eastern Red Cedar. According to the FDA-approved labeling for allergenic extracts, these products are indicated for patients whose symptoms are not adequately controlled by avoidance measures or pharmacological interventions like antihistamines and nasal corticosteroids.
Juniperus Virginiana Pollen works through a complex immunological process known as allergen-specific immunotherapy. When used diagnostically, the extract is introduced into the skin (epicutaneous or intradermal). If the patient has pre-existing IgE antibodies (immunoglobulin E) specific to the proteins in the Eastern Red Cedar pollen, these antibodies, which are bound to mast cells in the skin, will cross-link upon contact with the allergen. This results in the release of inflammatory mediators like histamine, causing a visible 'wheal and flare' reaction (a raised bump and redness).
When used therapeutically, the mechanism shifts toward inducing immunological tolerance. Your healthcare provider will administer gradually increasing doses of the pollen extract over several months. This process is thought to shift the body's immune response from a Th2-dominated profile (which promotes IgE production and allergic inflammation) to a Th1-dominated or T-regulatory (Treg) cell profile. This shift increases the production of 'blocking antibodies' (IgG4), which compete with IgE for allergen binding, and promotes the secretion of anti-inflammatory cytokines like IL-10 and TGF-beta. Over time, this reduces the sensitivity of mast cells and basophils, leading to a significant reduction in allergic symptoms upon natural exposure to the pollen.
As a biological extract containing a mixture of proteins, glycoproteins, and polysaccharides, Juniperus Virginiana Pollen does not follow traditional small-molecule pharmacokinetics (absorption, distribution, metabolism, and excretion).
Juniperus Virginiana Pollen extracts are FDA-approved for the following clinical indications:
Off-label use is rare, though some clinicians may use these extracts in customized sublingual (under the tongue) formulations, although many non-standardized extracts are not specifically FDA-labeled for sublingual use in the same way as certain standardized tablets.
Juniperus Virginiana Pollen is typically available in the following forms:
> Important: Only your healthcare provider can determine if Juniperus Virginiana Pollen is right for your specific condition. The selection of specific extracts for immunotherapy must be based on a thorough clinical history and confirmed diagnostic testing.
Dosage for Juniperus Virginiana Pollen is highly individualized and must be determined by an allergy specialist. There is no 'standard' dose for all patients because sensitivity levels vary significantly.
Treatment typically begins with a very dilute solution (e.g., 1:100,000 w/v or 1:10,000 w/v). Injections are usually given once or twice a week. The dose is incrementally increased (e.g., 0.05 mL, 0.10 mL, 0.20 mL) based on the patient's local reaction and tolerance. The goal is to reach the 'Maintenance Dose,' which is the highest dose the patient can tolerate without a systemic reaction.
Once the maintenance dose is reached (often a concentration of 1:100 or 1:20 w/v at a volume of 0.5 mL), the interval between injections is increased. Typically, maintenance injections are administered every 2 to 4 weeks. Treatment usually continues for 3 to 5 years to achieve long-lasting desensitization.
Juniperus Virginiana Pollen is used in children, generally starting at age 5 and older. The dosing schedule is similar to that of adults, but the physician may choose a more cautious build-up phase. Children should be closely monitored as they may be less able to articulate the early symptoms of a systemic reaction.
No specific dosage adjustments are required for patients with renal impairment, as the extract is not cleared by the kidneys in a way that would lead to toxicity. However, the patient's overall health should be stable before administration.
No dosage adjustments are typically necessary for hepatic impairment. The metabolic breakdown of proteins is independent of primary liver CYP450 enzyme systems.
Elderly patients (over 65) should be evaluated for cardiovascular stability. If an elderly patient is taking beta-blockers for hypertension or heart disease, the risk of immunotherapy may outweigh the benefits, as these drugs can interfere with the treatment of an accidental anaphylactic reaction.
If a dose is missed during the build-up phase, the next dose may need to be reduced or the previous dose repeated, depending on how much time has passed. If a dose is missed during the maintenance phase (e.g., more than 6 weeks since the last shot), the physician will typically reduce the dose for safety. Never attempt to 'double up' on doses.
An overdose in the context of allergenic extracts refers to receiving a dose higher than the patient's current tolerance level. This can lead to a severe systemic reaction or anaphylaxis.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or frequency without medical guidance from your allergist.
Most patients receiving Juniperus Virginiana Pollen immunotherapy will experience local reactions at the site of the injection.
> Warning: Stop taking Juniperus Virginiana Pollen and call your doctor or emergency services immediately if you experience any of these symptoms of anaphylaxis.
There are no known long-term 'toxic' side effects associated with Juniperus Virginiana Pollen when used correctly. The primary long-term effect is the desired modulation of the immune system. However, patients who receive immunotherapy for many years should be periodically re-evaluated to ensure the treatment is still necessary and effective. Some studies suggest that successful immunotherapy can prevent the development of new sensitivities to other allergens.
According to the FDA-mandated labeling for allergenic extracts:
Report any unusual symptoms, especially those occurring several hours after your injection, to your healthcare provider immediately.
Juniperus Virginiana Pollen is a potent biological product. Safety depends on accurate diagnosis, precise dosing, and strict adherence to administration protocols. It is not a 'cure' for allergies but a disease-modifying treatment that requires a commitment of several years. Patients must be communicative with their providers regarding any changes in their health status between injections.
No FDA black box warnings are specific ONLY to Juniperus Virginiana Pollen; however, it falls under the class-wide Black Box Warning for all Allergenic Extracts. This warning emphasizes that these products can cause anaphylaxis, must be administered by trained professionals, and require a 30-minute post-injection observation period. Severe reactions can occur even in patients who have previously tolerated the injections well.
Most patients can drive after the 30-minute observation period. However, if a patient experiences significant fatigue or a mild systemic reaction (e.g., feeling 'off' or dizzy), they should not drive until symptoms have completely resolved.
There is no direct chemical interaction between alcohol and Juniperus Virginiana Pollen. However, alcohol can cause vasodilation (widening of blood vessels), which could theoretically accelerate the absorption of the allergen or mask early signs of an allergic reaction. It is best to avoid alcohol for several hours after an injection.
Immunotherapy can be discontinued if the patient has been symptom-free for a significant period (usually after 3-5 years of treatment). There is no 'withdrawal syndrome' associated with stopping allergenic extracts, but allergic symptoms may eventually return if the desensitization was not complete.
> Important: Discuss all your medical conditions, especially heart or lung problems, with your healthcare provider before starting Juniperus Virginiana Pollen.
There are no known specific food interactions with Juniperus Virginiana Pollen. However, patients with 'Oral Allergy Syndrome' (cross-reactivity between certain pollens and fruits) should be aware that their food sensitivities might fluctuate during the build-up phase of immunotherapy.
For each major interaction, the mechanism is usually pharmacodynamic (affecting how the body responds to the allergen or the emergency treatment) rather than pharmacokinetic (affecting drug levels). The management strategy involves either substituting the interacting drug or pausing immunotherapy during periods of high risk.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially any medications for blood pressure or heart rhythm.
Juniperus Virginiana (Eastern Red Cedar) shows significant cross-reactivity with other members of the Cupressaceae family. This includes:
Patients allergic to Eastern Red Cedar are likely to react to these other species as well. Your healthcare provider will use this information to create a balanced 'mix' for your immunotherapy if you are sensitive to multiple trees in this family.
> Important: Your healthcare provider will evaluate your complete medical history, including heart and lung health, before prescribing Juniperus Virginiana Pollen.
FDA Pregnancy Category C. There are no adequate and well-controlled studies of Juniperus Virginiana Pollen in pregnant women.
Juniperus Virginiana Pollen extracts are not known to pass into breast milk in any clinically significant way. The large protein molecules are likely digested in the infant's gut if they were present. Immunotherapy is generally considered safe for breastfeeding mothers, but the mother should be monitored for systemic reactions as usual.
There are no specific guidelines for renal impairment. Since these are naturally occurring proteins that are degraded by proteases throughout the body, the kidneys do not play a primary role in their 'clearance.' However, if a patient is on dialysis, the timing of the injection should be discussed with the nephrologist.
No dosage adjustments are required for patients with liver disease. The liver's metabolic capacity for drugs (CYP450) is not involved in the processing of allergenic extracts.
> Important: Special populations require individualized medical assessment. Always inform your allergist if you become pregnant or develop new health problems.
Juniperus Virginiana Pollen extract functions as an immunomodulator. The molecular mechanism involves the presentation of allergen-derived peptides by Major Histocompatibility Complex (MHC) class II molecules on the surface of dendritic cells.
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous/Local) |
| Protein Binding | N/A (Degraded by proteases) |
| Half-life | Minutes to hours (for the proteins) |
| Tmax | 30-60 minutes (for systemic absorption) |
| Metabolism | Proteolytic cleavage into peptides |
| Excretion | Cellular metabolic pathways |
Juniperus Virginiana Pollen is a member of the Allergenic Extract class. It is specifically a Non-Standardized Pollen extract. Related medications include other tree pollens (Oak, Maple, Mountain Cedar) and standardized extracts like Grass or Ragweed. It is distinct from 'Standardized' extracts because its potency is not validated against a reference standard in a laboratory bioassay.
Common questions about Juniperus Virginiana Pollen
Juniperus Virginiana Pollen extract is primarily used for the diagnosis and treatment of seasonal allergies caused by the Eastern Red Cedar tree. In a clinical setting, it is used in skin prick tests to confirm if a patient is allergic to this specific pollen. For treatment, it is used in allergen immunotherapy, commonly known as allergy shots, to help the body build a tolerance over time. This can significantly reduce symptoms of hay fever, itchy eyes, and allergic asthma. It is typically reserved for patients who do not get enough relief from standard allergy medications.
The most common side effects are local reactions at the site of the injection, such as redness, swelling, and itching. These reactions usually appear shortly after the shot and go away within a day. Some patients may also experience a mild flare-up of their typical allergy symptoms, like sneezing or a runny nose. Fatigue is occasionally reported following the administration of the extract. While these are common, they are usually manageable and do not require stopping the treatment. However, any large or persistent swelling should be reported to your doctor.
There is no direct chemical interaction between alcohol and the pollen extract, but it is generally advised to avoid alcohol on the day of your injection. Alcohol can cause your blood vessels to dilate, which might speed up the absorption of the allergen into your bloodstream and increase the risk of a systemic reaction. Additionally, being under the influence of alcohol could make it harder for you to notice the early warning signs of an allergic reaction. It is best to wait at least several hours after your shot before consuming alcohol. Always consult your allergist for their specific office policy regarding alcohol.
Juniperus Virginiana Pollen is generally not started during pregnancy because of the risk of a severe allergic reaction (anaphylaxis), which could be dangerous for both the mother and the baby. However, if a woman is already on a stable maintenance dose and is tolerating it well, many allergists will allow her to continue the treatment. The extract itself is not known to cause birth defects. Decisions regarding immunotherapy during pregnancy are made on a case-by-case basis. You must inform your allergist immediately if you become pregnant or are planning to conceive.
Allergen immunotherapy is a long-term treatment and does not provide immediate relief like an antihistamine. Most patients begin to notice an improvement in their symptoms after they reach their maintenance dose, which usually takes 3 to 6 months of weekly injections. Significant benefits are typically seen after the first full year of treatment. For the best and most long-lasting results, the treatment is usually continued for 3 to 5 years. If no improvement is seen after a year of maintenance, your doctor may re-evaluate the treatment plan.
Yes, you can stop taking the injections suddenly without experiencing a 'withdrawal' in the traditional sense. Since it is an allergenic extract and not a drug like a steroid or an antidepressant, your body does not become physically dependent on it. However, if you stop the treatment before the recommended 3 to 5 years, your allergy symptoms are much more likely to return. If you miss several doses, you cannot simply restart at the same level; your doctor will need to reduce the dose for your safety. Always discuss your plans to stop treatment with your allergist first.
If you miss a dose, you should contact your allergist's office as soon as possible to reschedule. Do not attempt to take an extra dose later to make up for it. The safety of immunotherapy depends on the timing of the doses; if too much time passes between shots, your sensitivity to the allergen may increase. Depending on how many days or weeks have passed, your doctor may need to repeat your last dose or even reduce the dose slightly to prevent a reaction. Consistency is key to the success of the treatment.
There is no clinical evidence to suggest that Juniperus Virginiana Pollen or other allergenic extracts cause weight gain. These extracts consist of small amounts of natural proteins and do not contain hormones or calories that would affect your metabolism or appetite. If you experience weight gain while on immunotherapy, it is likely due to other factors, such as other medications (like oral steroids) or lifestyle changes. If you have concerns about weight changes, you should discuss them with your primary care physician.
Juniperus Virginiana Pollen can be taken with many other medications, but there are some critical exceptions. You should avoid taking beta-blockers, which are often used for heart conditions or migraines, as they can make allergic reactions harder to treat. Other medications like ACE inhibitors and certain antidepressants may also increase the risk or severity of reactions. Most standard allergy medications like antihistamines and nasal sprays are fine to continue. Always provide your allergist with a complete list of all medications and supplements you are using.
Allergenic extracts like Juniperus Virginiana Pollen are biological products rather than simple chemical drugs, so the term 'generic' does not apply in the same way. However, many different manufacturers produce Eastern Red Cedar pollen extracts. While they all contain the same basic allergen, they may differ in concentration and the way they are prepared (such as aqueous vs. glycerinated). Your allergist will select a high-quality extract from a reputable manufacturer, and once you start with one brand, they will typically try to keep you on that same brand for consistency.